GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » Receipts from Customers

CTOR (Citius Oncology) Receipts from Customers


View and export this data going back to 2024. Start your Free Trial

What is Citius Oncology Receipts from Customers?

Receipts from Customers only applicable to companies reporting Cash Flow from Operations in direct method.


Citius Oncology Business Description

Traded in Other Exchanges
N/A
Address
420 Lexington Ave, Suite 2446, New York, NY, USA, 10170
Website
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.